Taysha Gene Therapies Inc’s recently made public that its 10% Owner Manning Paul B acquired Company’s shares for reported $3.0 million on Jun 27 ’24. In the deal valued at $2.25 per share,1,333,333 shares were bought. As a result of this transaction, Manning Paul B now holds 1,333,333 shares worth roughly $2.04 million.
BMO Capital Markets initiated its Taysha Gene Therapies Inc [TSHA] rating to an Outperform in a research note published on June 27, 2024; the price target was $5. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in early April with a ‘”an Overweight”‘ rating. Jefferies also remained covering TSHA and has decreased its forecast on February 01, 2023 with a “Hold” recommendation from previously “Buy” rating. Morgan Stanley revised its rating on January 27, 2023. It rated TSHA as “an Equal-weight” which previously was an “an Overweight”.
Price Performance Review of TSHA
On Friday, Taysha Gene Therapies Inc [NASDAQ:TSHA] saw its stock fall -3.16% to $1.53. Over the last five days, the stock has lost -13.07%. Taysha Gene Therapies Inc shares have fallen nearly -11.56% since the year began. Nevertheless, the stocks have fallen -3.47% over the past one year. While a 52-week high of $4.32 was reached on 01/07/25, a 52-week low of $1.19 was recorded on 01/17/25. SMA at 50 days reached $2.0763, while 200 days put it at $2.3518.
Levels Of Support And Resistance For TSHA Stock
The 24-hour chart illustrates a support level at 1.4883, which if violated will result in even more drops to 1.4467. On the upside, there is a resistance level at 1.5933. A further resistance level may holdings at 1.6567. The Relative Strength Index (RSI) on the 14-day chart is 34.16, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1793, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 96.43%. Stochastics %K at 8.28% indicates the stock is a buying.
How much short interest is there in Taysha Gene Therapies Inc?
A steep rise in short interest was recorded in Taysha Gene Therapies Inc stocks on 2024-12-31, growing by 10.21 million shares to a total of 25.88 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 15.67 million shares. There was a rise of 39.45%, which implies that there is a positive sentiment for the stock.
